Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Jeong-Ran Kim"'
Autor:
Minsuk Kim MD, Si-Hyuck Kang MD, Jeong-Ran Kim BS, Jin Joo Park MD, Young-seok Cho MD, Tae-Jin Youn MD, In-Ho Chae MD, Jung-Won Suh MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Shear stress (SS)-induced platelet activation is suggested as an essential mechanism of the acute coronary syndrome (ACS). We aimed to compare SS-induced thrombotic and thrombolytic activities among 3 treatment regimens in patients with ACS who under
Externí odkaz:
https://doaj.org/article/ba5138a5ff804ddf821de3cf848a4922
Autor:
Jeong-Ran Kim
Publikováno v:
Hanminjok Emunhak. 96:91-126
Autor:
Jeong-ran Kim
Publikováno v:
Hanminjok Emunhak. 94:143-177
Autor:
Jeong-Ran Kim
Publikováno v:
Cultural Interaction Studies of Sea Port Cities. 25:1-38
Autor:
Jeong-Ran Kim, Myoung-Kwang Kim
Publikováno v:
Korean Association For Learner-Centered Curriculum And Instruction. 21:15-36
Autor:
Jeong-ran Kim
Publikováno v:
Hanminjok Emunhak. 90:45-78
Autor:
Sun-Hyung Ha, Young-Choon Lee, Hyunju Choi, Cheorl-Ho Kim, Fukushi Abekura, Jun-Young Park, Jeong-Ran Kim
Publikováno v:
Inflammation. 43:54-65
20pt?>Mycobacterium tuberculosis (Mtb) is a pathogenic bacterium that causes contagious tuberculosis (TB). Recently, Mtb-secreted proteins have been considered virulence factors and candidates for drugs and vaccines. Among these proteins, 6-kDa early
Publikováno v:
Current Pharmaceutical Biotechnology. 20:562-572
Background:Interferon-gamma release assays (IGRAs) are blood tests used to measure the amount of interferon-γ (IFN-γ) released by T lymphocytes after stimulation by antigens specific for the diagnosis of latent tuberculosis infection. A mitogen ser
Autor:
Jeong-Ran Kim1
Publikováno v:
Social Science Diliman. Jul-Dec2018, Vol. 14 Issue 2, p26-48. 23p.
Publikováno v:
Clinical Rheumatology.
We compared the performance of a fluorescence lateral flow assay (ichroma™ IGRA-TB) with the QuantiFERON-TB Gold PLUS (QFT-PLUS) for the diagnosis of latent tuberculosis infection (LTBI) in patients with immune-mediated inflammatory diseases (IMID)